ANI Pharmaceuticals Statistics

Total Valuation

BST:BSFA has a market cap or net worth of EUR 1.50 billion. The enterprise value is 1.87 billion.

Market Cap	1.50B
Enterprise Value	1.87B

Important Dates

The last earnings date was Thursday, August 7, 2025.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	20.09M
Shares Outstanding	n/a
Shares Change (YoY)	+0.97%
Shares Change (QoQ)	+1.31%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	16.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	11.88
PS Ratio	2.36
PB Ratio	3.82
P/TBV Ratio	n/a
P/FCF Ratio	14.05
P/OCF Ratio	12.67
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.47, with an EV/FCF ratio of 17.49.

EV / Earnings	-172.65
EV / Sales	2.93
EV / EBITDA	20.47
EV / EBIT	110.44
EV / FCF	17.49

Financial Position

The company has a current ratio of 2.54, with a Debt / Equity ratio of 1.36.

Current Ratio	2.54
Quick Ratio	1.90
Debt / Equity	1.36
Debt / EBITDA	5.88
Debt / FCF	5.01
Interest Coverage	0.63

Financial Efficiency

Return on equity (ROE) is -2.17% and return on invested capital (ROIC) is 1.33%.

Return on Equity (ROE)	-2.17%
Return on Assets (ROA)	1.09%
Return on Invested Capital (ROIC)	1.33%
Return on Capital Employed (ROCE)	1.79%
Revenue Per Employee	709,487
Profits Per Employee	-12,061
Employee Count	897
Asset Turnover	0.66
Inventory Turnover	2.21

Taxes

Income Tax	-3.86M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +40.57% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+40.57%
50-Day Moving Average	56.47
200-Day Moving Average	55.63
Relative Strength Index (RSI)	89.45
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.30

Income Statement

In the last 12 months, BST:BSFA had revenue of EUR 636.41 million and -10.82 million in losses. Loss per share was -0.55.

Revenue	636.41M
Gross Profit	388.62M
Operating Income	16.86M
Pretax Income	-12.56M
Net Income	-10.82M
EBITDA	88.83M
EBIT	16.86M
Loss Per Share	-0.55

Full Income Statement

Balance Sheet

The company has 190.32 million in cash and 534.96 million in debt, giving a net cash position of -344.64 million.

Cash & Cash Equivalents	190.32M
Total Debt	534.96M
Net Cash	-344.64M
Net Cash Per Share	n/a
Equity (Book Value)	393.06M
Book Value Per Share	18.48
Working Capital	311.47M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 118.48 million and capital expenditures -11.66 million, giving a free cash flow of 106.81 million.

Operating Cash Flow	118.48M
Capital Expenditures	-11.66M
Free Cash Flow	106.81M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 61.06%, with operating and profit margins of 2.65% and -1.37%.

Gross Margin	61.06%
Operating Margin	2.65%
Pretax Margin	-1.97%
Profit Margin	-1.37%
EBITDA Margin	13.96%
EBIT Margin	2.65%
FCF Margin	16.78%

Dividends & Yields

BST:BSFA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.97%
Shareholder Yield	-0.97%
Earnings Yield	-0.72%
FCF Yield	7.12%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BST:BSFA has an Altman Z-Score of 1.67 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.67
Piotroski F-Score	4